Cargando…

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition

BACKGROUND: Currently, Atypical Teratoid Rhabdoid Tumor (AT/RT) constitutes one of the most difficult to treat malignancies in pediatrics. Hence, new knowledge of potential targets for therapeutics and the development of novel treatment approaches are urgently needed. We have evaluated the presence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayanthan, Aarthi, Bernoux, Delphine, Bose, Pinaki, Riabowol, Karl, Narendran, Aru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278350/ https://www.ncbi.nlm.nih.gov/pubmed/22206574 http://dx.doi.org/10.1186/1475-2867-11-44

Ejemplares similares

Aurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents
por: Jayanthan, Aarthi, et al.
Publicado: (2014)

Survivin as a Preferential Target for Cancer Therapy
por: Mobahat, Mahsa, et al.
Publicado: (2014)

Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
por: Hoeksema, Kimberley A, et al.
Publicado: (2011)

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
por: Aveic, Sanja, et al.
Publicado: (2018)

Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers
por: Standing, Shaelene, et al.
Publicado: (2022)

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
por: Andersson, Mattias K, et al.
Publicado: (2008)

Development and validation of a 21-gene prognostic signature in neuroblastoma
por: Gupta, Mehul, et al.
Publicado: (2023)

Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs
por: Kenig, Saša, et al.
Publicado: (2016)

Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
por: Uhl, Katie L., et al.
Publicado: (2018)

Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines
por: Zhou, Dong-Hui, et al.
Publicado: (2015)

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
por: Silveira, Elaine, et al.
Publicado: (2018)

REAP: A two minute cell fractionation method
por: Suzuki, Keiko, et al.
Publicado: (2010)

Receptor Tyrosine Kinases: Molecular Switches Regulating CNS Axon Regeneration
por: Vigneswara, Vasanthy, et al.
Publicado: (2012)

Characterization of a bacterial tyrosine kinase in Porphyromonas gingivalis involved in polymicrobial synergy
por: Wright, Christopher J, et al.
Publicado: (2014)

Lin28A/let-7 oncogenic circuit is a potential therapeutic target in neurocutaneous melanosis-associated CNS tumors in children
por: Jain, Mohit, et al.
Publicado: (2020)

Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma
por: Wang, Liang, et al.
Publicado: (2020)

Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
por: Cui, Ranliang, et al.
Publicado: (2021)

A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials
por: Targum, Steven D, et al.
Publicado: (2013)

Interspecies data mining to predict novel ING-protein interactions in human
por: Gordon, Paul MK, et al.
Publicado: (2008)

Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy
por: Kim, Yoonjung, et al.
Publicado: (2021)

Potential mechanism of phytochemical-induced apoptosis in human prostate adenocarcinoma cells: Therapeutic synergy in genistein and β-lapachone combination treatment
por: Kumi-Diaka, James, et al.
Publicado: (2004)

7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis
por: Miettunen, PM, et al.
Publicado: (2008)

Improved accuracy and reduced uncertainty in greenhouse gas inventories by refining the IPCC emission factor for direct N(2)O emissions from nitrogen inputs to managed soils
por: Hergoualc’h, Kristell, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC
por: Gal, Omer, et al.
Publicado: (2020)

LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
por: Choi, Seung Ah, et al.
Publicado: (2016)

Upregulation of microRNA 344a-3p is involved in curcumin induced apoptosis in RT4 schwannoma cells
por: Sohn, Eun Jung, et al.
Publicado: (2018)

Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR
por: Lian, Wenping, et al.
Publicado: (2020)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
por: Saronni, Davide, et al.
Publicado: (2022)

Preclinical Models: Boosting Synergies for Improved Translation
por: Attanasio, Chiara, et al.
Publicado: (2020)

Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation
por: Iriyama, Noriyoshi, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
por: Arciniegas Ruiz, Sara Melisa, et al.
Publicado: (2022)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
por: Bi, Jianling, et al.
Publicado: (2021)

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
por: Zujewski, JoAnne, et al.
Publicado: (2001)

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells
por: Jiang, Yuelong, et al.
Publicado: (2022)

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients
por: Bose, Pinaki, et al.
Publicado: (2014)

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells
por: Hurtubise, Annie, et al.
Publicado: (2008)

Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
por: Torke, Sebastian, et al.
Publicado: (2020)

Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines
por: Leclerc, Guy J, et al.
Publicado: (2002)

Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study
por: Wen, Dong-yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qh5v7fgds8njek9ian6l6mveu9